Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Cryoport, Inc.

CYRX · Nasdaq · CIK 0001124524 · Healthcare · Integrated Freight & Logistics

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

12 Form 4 transaction lines observed in the same window
5 sales · 7 option, withholding, award, gift or other lines

Last qualifying purchaseNo qualifying purchase is present in the local Form 4 history.

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
ZECCHINI EDWARD JChief Digital and Tech Officer
○▼○▼
Mandalam RamkumarDirector
○▼
SHELTON JERRELLPresident, CEO
○▼
BADDOUR LINDADirector
○
HANCOCK DANIEL MDirector
○
Hariri Robert JDirector
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot.—

Recent Form 4 activity

0Purchases
14Sales
13Other Form 4 lines
17SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING5 sale line(s) · context only
OTHER7 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
2,362,636
Previous report
2,786,514
Avg daily volume
698,414
Days to cover
3.4

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

No qualifying code P equity purchase is present in the local Form 4 history.

Form 4 evidence

27 transaction lines in the latest 365-day window; 317 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-11SHELTON JERRELLSale (S)Common Stock28,800USD 14.91USD 429,408SEC filing ↗
2026-06-11ZECCHINI EDWARD JSale (S)Common Stock33,600USD 14.47USD 486,192SEC filing ↗
2026-06-11ZECCHINI EDWARD JOption exercise / conversion (M)Common Stock33,600USD 4.80USD 161,280SEC filing ↗
Show recent Form 4 evidence (27 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-11SHELTON JERRELLSale (S)Common Stock28,800USD 14.91USD 429,408SEC filing ↗
2026-06-11ZECCHINI EDWARD JSale (S)Common Stock33,600USD 14.47USD 486,192SEC filing ↗
2026-06-11ZECCHINI EDWARD JOption exercise / conversion (M)Common Stock33,600USD 4.80USD 161,280SEC filing ↗
2026-06-10ZECCHINI EDWARD JSale (S)Common Stock1,400USD 15.23USD 21,322SEC filing ↗
2026-06-10ZECCHINI EDWARD JOption exercise / conversion (M)Common Stock1,400USD 4.80USD 6,720SEC filing ↗
2026-06-08Mandalam RamkumarSale (S)Common Stock23,214USD 15.44USD 358,424SEC filing ↗
2026-06-05BADDOUR LINDAAward / grant (A)Common Stock10,350USD 0.00USD 0SEC filing ↗
2026-06-05Mandalam RamkumarAward / grant (A)Common Stock10,350USD 0.00USD 0SEC filing ↗
2026-06-05Hariri Robert JAward / grant (A)Common Stock10,350USD 0.00USD 0SEC filing ↗
2026-06-05HANCOCK DANIEL MAward / grant (A)Common Stock10,350USD 0.00USD 0SEC filing ↗
2026-06-04STEFANOVICH ROBERTSale (S)Common Stock169,427USD 16.27USD 2,756,577SEC filing ↗
2026-04-21SHELTON JERRELLOption exercise / conversion (M)Common Stock104,007USD 1.87USD 194,493SEC filing ↗
2026-04-06SHELTON JERRELLOption exercise / conversion (M)Common Stock50,000USD 1.87USD 93,500SEC filing ↗
2026-03-23Sawicki Mark WSale (S)Common Stock1,341USD 8.18USD 10,969SEC filing ↗
2026-03-23STEFANOVICH ROBERTSale (S)Common Stock1,094USD 8.18USD 8,949SEC filing ↗
2026-03-23SHELTON JERRELLSale (S)Common Stock2,894USD 8.18USD 23,673SEC filing ↗
2026-03-23SHELTON JERRELLOption exercise / conversion (M)Common Stock25,000USD 1.87USD 46,750SEC filing ↗
2026-03-16ZECCHINI EDWARD JSale (S)Common Stock2,014USD 8.00USD 16,112SEC filing ↗
2026-03-16Sawicki Mark WSale (S)Common Stock3,235USD 8.00USD 25,880SEC filing ↗
2026-03-16SHELTON JERRELLSale (S)Common Stock7,918USD 8.00USD 63,344SEC filing ↗
2026-03-16STEFANOVICH ROBERTSale (S)Common Stock2,743USD 8.00USD 21,944SEC filing ↗
2026-03-14ZECCHINI EDWARD JAward / grant (A)Common Stock21,322USD 0.00USD 0SEC filing ↗
2026-03-14Sawicki Mark WAward / grant (A)Common Stock22,845USD 0.00USD 0SEC filing ↗
2026-03-14STEFANOVICH ROBERTAward / grant (A)Common Stock27,413USD 0.00USD 0SEC filing ↗
2026-03-12STEFANOVICH ROBERTSale (S)Common Stock38,700USD 7.76USD 300,312SEC filing ↗
2026-03-12STEFANOVICH ROBERTOption exercise / conversion (M)Common Stock87,188USD 1.87USD 163,042SEC filing ↗
2025-12-10Mandalam RamkumarSale (S)Common Stock11,570USD 9.99USD 115,584SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerCYRX
CIK0001124524
SectorHealthcare
IndustryIntegrated Freight & Logistics Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history317 transaction lines from 2020-02-05 to 2026-08-11
0 P purchase lines · 147 S sale lines · 170 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.